The Classification of Vitreous Seeds in Retinoblastoma and Response to Intravitreal Melphalan
- 1 June 2015
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 122 (6), 1173-1179
- https://doi.org/10.1016/j.ophtha.2015.01.017
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Local and Systemic Toxicity of Intravitreal Melphalan for Vitreous Seeding in RetinoblastomaOphthalmology, 2014
- Combined Intravitreal Melphalan and Topotecan for Refractory or Recurrent Vitreous Seeding From RetinoblastomaJAMA Ophthalmology, 2014
- Death by Water: Precautionary Water Submersion for Intravitreal Injection of Retinoblastoma EyesThe Open Ophthalmology Journal, 2014
- Intravitreal Melphalan for Persistent or Recurrent Retinoblastoma Vitreous SeedsJAMA Ophthalmology, 2014
- A 10‐year experience of outcome in chemotherapy‐treated hereditary retinoblastomaActa Ophthalmologica, 2013
- Long‐term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low‐dose IMRT salvagePediatric Blood & Cancer, 2012
- Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indicationsBritish Journal of Ophthalmology, 2012
- Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year resultsBritish Journal of Ophthalmology, 2011
- Intraocular Retinoblastoma: the Case for a New Group ClassificationOphthalmology Clinics of North America, 2005
- Retreatment of Retinoblastoma With External Beam IrradiationAmerican Journal of Ophthalmology, 1982